Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 71Neoplasms 70Lung Neoplasms 29Prostatic Neoplasms 26Head and Neck Neoplasms 22Colorectal Neoplasms 19Uterine Cervical Neoplasms 17Ovarian Neoplasms 13Neoplasm Metastasis 13Motor Activity 13Fatigue 11Endometrial Neoplasms 11Colonic Neoplasms 11Brain Neoplasms 11Pain 10Carcinoma, Non-Small-Cell Lung 10Multiple Myeloma 9Melanoma 9Rectal Neoplasms 8Leukemia 8Gastrointestinal Neoplasms 8Smoking Cessation 7Pancreatic Neoplasms 7Lymphoma 7Depression 7cyclopia sequence 6Esophageal Neoplasms 6Carcinoma, Renal Cell 6Advanced Cancer 6Uterine Neoplasms 5

Interventions

Bevacizumab 3Radiosurgery 2Irinotecan 2pembrolizumab 1Vorinostat 1Valproic Acid 1Thalidomide 1Temozolomide 1Surveys and Questionnaires 1Sorafenib 1Sildenafil Citrate 1Pliability 1Nivolumab 1Morphine 1Methadone 1Exercise 1Equipment and Supplies 1Eating 1Carboplatin 1Amifampridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurologic Manifestations × Surveys and Questionnaires × Clear all
NCT03026699 2020-12-02

Refining and Testing the Electronic Social Network Assessment Program (eSNAP)

H. Lee Moffitt Cancer Center and Research Institute

Completed
62 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡